Award
National Institute on Drug Abuse 4R44DA059517-02
Cue-induced drug craving monitoring for opioid use disorder with visual evoked potentials
Recipient
Not Specified
Award Amount
$870,345.00
Ceiling
$870,345.00
Awarded
May 14, 2026
Identifier
4R44DA059517-02
Award for developing a device to monitor drug craving in opioid use disorder patients using EEG technology, funded by NIDA for a clinical trial.
Description
The project aims to create a regulated device to monitor Cue-Induced Craving (CIC) in Opioid Use Disorder (OUD) patients by integrating EEG technology with software to predict clinical outcomes. It is a Phase I/II clinical trial focusing on safety, efficacy, and FDA approval.